Potential for Targeting Myeloid Cells in Controlling CNS Inflammation

Area of Science:

• Neuroimmunology
• Cellular Biology

Background:

• Multiple Sclerosis (MS) involves immune cell infiltration and myelin loss in the central nervous system (CNS).
• MS lesions show significant accumulation of myeloid cells, including macrophages and dendritic cells (DCs).
• The experimental autoimmune encephalomyelitis (EAE) model highlights the role of peripheral myeloid cells in MS pathology.

Purpose of the Study:

• To review emerging strategies targeting myeloid cells for Multiple Sclerosis treatment.
• To discuss the translation of human and mouse study data into clinical applications.

Main Methods:

• Review of current clinical trial strategies.
• Analysis of data from human and mouse studies on myeloid cell involvement in MS.
• Focus on targeting myeloid cell migration, growth factors, cytokines, biological functions (miRNAs), and immunological activities (nanoparticles).

Main Results:

• Multiple therapeutic strategies targeting myeloid cells are advancing in clinical trials.
• These strategies are informed by a growing understanding of myeloid cell roles in MS pathogenesis.
• Diverse approaches include modulating cell migration, growth factors, miRNAs, and utilizing nanoparticles.

Conclusions:

• Targeting myeloid cells represents a promising therapeutic avenue for Multiple Sclerosis.
• Current research and clinical trials are exploring novel ways to modulate myeloid cell functions for MS treatment.
• A shift towards myeloid-centric therapies may offer new hope for MS patients.